Australia’s opportunity to turn biotech into global growth
How Australian biotech can use funding, clinical research and global markets to drive growth.
Beyond the numbers: Explore the trends and ideas shaping Australian business. Listen now.
17 Apr 2025 4 min read
The R&D Tax Incentive (RDTI) is the Federal Government’s flagship program to support and encourage innovation, research and development activities undertaken in Australia. This program is available to companies across a broad range of industries and business activities.
The RDTI has several levels of support including a refundable offset equal to the company’s corporate tax rate plus an 18.5 per cent premium where annual aggregated turnover is less than $20m (grouping rules apply). In some cases, this could result in a cash refund from the ATO.
Alternatively, if turnover is greater than $20m (grouping rules apply), the offset is non-refundable but can be carried forward. The offset rate is equal to the company’s corporate tax rate plus 8.5 per cent, up to 16.5 per cent determined by the R&D intensity for the income year. The higher rate is available to companies that achieve an R&D intensity of greater than 2 per cent of their total expenses.
To register your R&D activities with the Department of Innovation, Science and Resources (DISR) you must submit your R&D Application no later than 10 months after your company year-end. For companies with a 30 June year-end, the deadline to lodge your R&D Application is 30 April 2025.
If a company does not lodge an R&D Application before the deadline, it risks permanently losing the ability to make an RDTI claim for that financial year.
As the RDTI is a self-assessment based program, it is critical that you consider the R&D eligibility criteria, legislative requirements, guidance, and alerts as part of preparing your R&D Application Form. Further, companies should ensure that they have documentation to substantiate the eligibility of any R&D activities in line with the legislative criteria in the event of a review, audit by AusIndustry, or the ATO.
Our national team of experts is here to assist you with the R&D Tax Incentive claim process. We can help you determine eligibility, review your R&D documentation, and ensure your application is lodged correctly and on time.
Our specialists can assist with:
If you have any questions or need assistance with your R&D Tax Incentive claim, please do not hesitate to contact us. We are here to support you every step of the way.
How Australian biotech can use funding, clinical research and global markets to drive growth.
R&D Tax Incentive reforms, RDTI reforms, R&D tax offset, innovation incentives, refundable R&D offset, non-refundable R&D offset, supporting R&D activities, Treasury consultation, research and development tax incentive, Federal Budget 2026-27, R&D tax changes, Australia R&D incentives, Innovation Incentives, R&D claims
In this edition of our Australian International Tax Update, we summarise recent significant Australian tax developments, examine their practical impact, and outline actions that multinational groups, foreign investors, private equity funds and international advisers should consider.